The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...
Eli Lilly (LLY, Financial) is set to pivot its focus beyond obesity after a monumental windfall from its GLP-1 drugs. At its ...
Pharmaceutical company Eli Lilly (LLY) has been raking it in lately thanks to its two flagship products: Mounjaro and Zepbound. These two have ...
Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by recording nearly $550 million in "pre-launch inventory" in its financial ...
Several individuals enrolled in a phase 3 trial for Eli Lilly's (NYSE:LLY) next-generation obesity drug, retatrutide, say ...
Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
Bonnie Blue, known for setting a world record of sleeping with 1,057 men, is expecting. Lilly Phillips, who made headlines ...
Former Tennessee football offensive lineman Trey Teague is sharing lessons learned in Knoxville with his daughter, Lilly, a ...
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...
Providence, Rhode Island; Friday, 7 p.m. EST BOTTOM LINE: Brown hosts Columbia after Kino Lilly Jr. scored 23 points in Brown's 82-72 victory over the Pennsylvania Quakers. The Bears are 7-4 on their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results